Nahla Ibrahim

Ms. Nahla Ibrahim

Medical University of Vienna

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HHHubert Hayden
Hubert Hayden
NINahla Ibrahim
Nahla Ibrahim
JKJohannes Klopf
Johannes Klopf
BZBranislav Zagrapan
Branislav Zagrapan
LMLisa-Marie Mauracher
Lisa-Marie Mauracher
CBChristine Brostjan
Christine Brostjan
Over the past years, neutrophil extracellular traps (NETs) were shown to contribute to states of acute and chronic inflammatory disease. They are composed of expelled chromatin and decorated by neutrophil-derived proteins. Therefore, the analysis of DNA complexes with myeloperoxidase (MPO) by ELISA has become an attractive tool to measure NET formation inin vitroandin vivosamples. When we used a published MPO-DNA ELISA protocol and included an isotype control for the anti-MPO coating antibody, we observed high assay specificity forin vitroprepared NET samples, whereas the specificity forin vivoplasma samples was low. In addition, the assay failed to detectin vitrogenerated MPO-DNA complexes when spiked into plasma. Therefore, we set out to improve the specificity of the MPO-DNA ELISA for plasma samples. We found that the use of Fab fragments or immunoglobulins from different species or reversal of the antibody pair led to either a high background or a low dynamic range of detection that did not improve the specificity for plasma samples. Also, the use of higher plasma dilutions or pre-clearing of plasma immunoglobulins were ineffective. Finally, we found that a commercial reagent designed to block human anti-mouse antibodies and multivalent substances increased the detection window between the MPO antibody and isotype control for highly diluted plasma. We applied this modified ELISA protocol to analyze MPO-DNA complexes in human blood samples of acute and chronic inflammatory conditions. While markers of neutrophil activation and NET formation such as MPO, elastase and citrullinated histone H3 correlated significantly, we observed no correlation with the levels of MPO-DNA complexes. Therefore, we conclude that ELISA measurements of MPO-DNA complexes in human plasma are highly questionable regarding specificity of NET detection. In general, plasma analyses by ELISA should more frequently include isotype controls for antibodies to demonstrate target specificity.

1 July 2021 in Translational Research
Verified
Journal Article
Open access
WEWolf Eilenberg
Wolf Eilenberg
BZBranislav Zagrapan
Branislav Zagrapan
SBSonja Bleichert
Sonja Bleichert
NINahla Ibrahim
Nahla Ibrahim
VKViktoria Knöbl
Viktoria Knöbl
CBChristine Brostjan
Christine Brostjan
Neutrophil extracellular traps (NETs) have been implicated in the pathogenesis of abdominal aortic aneurysms (AAAs). This study has addressed the notion that NET components might serve as AAA biomarkers or novel targets of AAA therapy. Thus, parameters of neutrophil activation and NET formation were measured in plasma. Their diagnostic marker value was explored in 41 AAA patients and 38 healthy controls. The NET parameter citrullinated histone H3 (citH3) was then validated in 63 AAA patients and 63 controls matched for cardiovascular disease. The prognostic marker potential was investigated in 54 observation periods of AAA growth over 6 months. NETs were further assessed in conditioned medium and sections of aortic tissue. CitH3 was found to be increased in blood (median 362 vs. 304 ng/ml, p=0.004) and aortic tissue (50 vs. 1.5 ng/mg, p<0.001) of AAA patients compared to healthy controls and accumulated in the intraluminal thrombus (629 ng/mg). The diagnostic potential of citH3 ranged at 0.705 area under the ROC curve (AUROC) and was validated with the independent sample set. Furthermore, plasma citH3 predicted AAA growth over the next 6 months (AUROC: 0.707, p=0.015) and dropped significantly after surgical aneurysm repair. In an angiotensin II - based mouse model of experimental AAA, an inhibitor of histone citrullination was applied to block NET formation and AAA progression. Of note, further growth of an established aneurysm was prevented in mice treated with the NET inhibitor (p=0.040). In conclusion, histone citrullination represents a promising AAA biomarker and potential therapeutic target to control disease progression.

3 March 2021 in JVS-Vascular Science
Verified
Journal Article
Open access
ABAlbert Busch
Albert Busch
SBSonja Bleichert
Sonja Bleichert
NINahla Ibrahim
Nahla Ibrahim
MWMarkus Wortmann
Markus Wortmann
HEHans-Henning Eckstein
Hans-Henning Eckstein
LMLars Maegdefessel
Lars Maegdefessel
Abdominal aortic aneurysm (AAA) is a condition that has considerable socioeconomic impact and an eventual rupture is associated with high mortality and morbidity. Despite decades of research, surgical repair remains the treatment of choice and no medical therapy is currently available. Animal models and, in particular, murine models, of AAA are a vital tool for experimental in vivo research. However, each of the different models has individual limitations and provide only partial mimicry of human disease. This narrative review addresses the translational potential of the available mouse models, highlighting unanswered questions from a clinical perspective. It is based on a thorough presentation of the available literature and more than a decade of personal experience, with most of the available models in experimental and translational AAA research. From all the models published, only the four inducible models, namely the angiotensin II model (AngII), the porcine pancreatic elastase perfusion model (PPE), the external periadventitial elastase application (ePPE), and the CaCl2 model have been widely used by different independent research groups. Although the angiotensin II model provides features of dissection and aneurysm formation, the PPE model shows reliable features of human AAA, especially beyond day 7 after induction, but remains technically challenging. The translational value of ePPE as a model and the combination with β-aminopropionitrile to induce rupture and intraluminal thrombus formation is promising, but warrants further mechanistic insights. Finally, the external CaCl2 application is known to produce inflammatory vascular wall thickening. Unmet translational research questions include the origin of AAA development, monitoring aneurysm growth, gender issues, and novel surgical therapies as well as novel nonsurgical therapies. New imaging techniques, experimental therapeutic alternatives, and endovascular treatment options provide a plethora of research topics to strengthen the individual features of currently available mouse models, creating the possibility of shedding new light on translational research questions.

10 January 2024 in JACC: Basic To Translational Science
Verified
Journal Article
Open access
NINahla Ibrahim
Nahla Ibrahim
SBSonja Bleichert
Sonja Bleichert
JKJohannes Klopf
Johannes Klopf
GKGabriel Kurzreiter
Gabriel Kurzreiter
HHHubert Hayden
Hubert Hayden
CBChristine Brostjan
Christine Brostjan
• For AAA, surgical repair remains the only treatment to date, with a lack of drug options for management of aneurysm progression or rupture risk. • NETs are implicated in the pathogenesis of cardiovascular diseases, including AAA, atherosclerosis, and thrombosis. The present study compared the therapeutic potential of distinct NET inhibitors on murine AAA by targeting major upstream or downstream effector molecules of NET formation. • NET inhibition, in particular blockade of upstream NET mediators, prevented progression of AngII-induced aneurysms, in which treatment success was dependent on thrombus formation, which is a frequent feature of established human disease. • These findings may also be of relevance to other NET-driven conditions and the current efforts to develop NET-targeting drugs for clinical application.

Verified
Journal Article
Open access
PDF file
NINahla Ibrahim
Nahla Ibrahim
WEWolf Eilenberg
Wolf Eilenberg
CNChristoph Neumayer
Christoph Neumayer
CBChristine Brostjan
Christine Brostjan
Neutrophil extracellular traps (NETs), composed of DNA, histones, and antimicrobial proteins, are released by neutrophils in response to pathogens but are also recognized for their involvement in a range of pathological processes, including autoimmune diseases, cancer, and cardiovascular diseases. This review explores the intricate roles of NETs in different cardiovascular conditions such as thrombosis, atherosclerosis, myocardial infarction, COVID-19, and particularly in the pathogenesis of abdominal aortic aneurysms. We elucidate the mechanisms underlying NET formation and function, provide a foundational understanding of their biological significance, and highlight the contribution of NETs to inflammation, thrombosis, and tissue remodeling in vascular disease. Therapeutic strategies for preventing NET release are compared with approaches targeting components of formed NETs in cardiovascular disease. Current limitations and potential avenues for clinical translation of anti-NET treatments are discussed.

12 November 2018 in Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
KSKatharina Seif
Katharina Seif
LALejla Alidzanovic
Lejla Alidzanovic
BTBarbara Tischler
Barbara Tischler
NINahla Ibrahim
Nahla Ibrahim
BZBranislav Zagrapan
Branislav Zagrapan
CBChristine Brostjan
Christine Brostjan
Thrombospondin-1 (TSP-1) is primarily expressed by platelets and endothelial cells (ECs) and rapidly released upon their activation. It functions in haemostasis as a bridging molecule in platelet aggregation, by promoting platelet adhesion to collagen and by protecting von Willebrand factor strings from degradation. In blood of patients undergoing surgery and in co-cultures of neutrophils with platelets or ECs, we observed proteolysis of the 185 kDa full-length TSP-1 to a 160-kDa isoform. We hypothesized that TSP-1 processing may alter its haemostatic properties. Selective enzyme inhibitors in co-cultures revealed that neutrophil proteases elastase and cathepsin G mediate TSP-1 processing. The cut site of cathepsin G was mapped to TSP-1 amino acids R237/T238 by Edman sequencing. Formation of neutrophil extracellular traps protected TSP-1 from complete degradation and promoted controlled processing to the 160-kDa isoform. Haemostatic properties were tested by platelet aggregation, adhesion, coagulation and string formation under flow. Platelets from TSP-1 deficient mice did not differ from wild-type in platelet aggregation but showed severe impairment of platelet adhesion to collagen and string formation under flow. Reconstitution experiments revealed that the 160-kDa TSP-1 isoform was markedly more potent than the 185-kDa full-length molecule in restoring function. Thus, TSP-1 processing by neutrophil proteases yields a 160-kDa isoform which shows enhanced potency to promote platelet adhesion and string formation. This finding reveals a novel mechanism of neutrophil-mediated thrombus formation and provides first evidence for the impact of TSP-1 proteolysis on its haemostatic properties.